Preclinical efficacy of LP-184, a tumor site activated synthetic lethal therapeutic, in glioblastoma

Glioblastoma (GBM), is the most common brain malignancy with median survival

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2023-10, Vol.29 (20), p.4209-4218
Main Authors: Lal, Bachchu, Kulkarni, Aditya, McDermott, Joseph, Rais, Rana, Alt, Jesse, Wu, Ying, Lopez-Bertoni, Hernando, Sall, Sophie, Kathad, Umesh, Zhou, Jianli, Slusher, Barbara S, Bhatia, Kishor, Laterra, John
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glioblastoma (GBM), is the most common brain malignancy with median survival
ISSN:1078-0432
1557-3265
DOI:10.1158/1078-0432.CCR-23-0673